EUVIMEDEUVIMED entdecken
Multizentrische Studie

Pediatric Cerebral Sinus Venous Thrombosis During the First Three Years of the SARS‐CoV‐2 Pandemic: A Multinational Case Series

Marcela Torres, Allyson Schenk iD, Riten Kumar iD, Laura Lehman, Sahar M A Hassanein, Catherine Amlie-Lefond, Timothy J Bernard, Beth Anne Cavanaugh, Arpita Lakhotia, Nomazulu Dlamini, Jonathan D Santoro iD, J Michael Taylor und 3 weitere

Pediatric Blood & Cancer · 2026-10 · 73 (10)

DOI: 10.1002/1545-5017.70566 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 31.07.2026. Verfasst von Marcela Torres und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Cook Children's Hematology and Oncology Center, Fort Worth, Texas, USA. Hauptthemen laut MEDLINE: COVID-19, Sinus Thrombosis, Intracranial, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Coronavirus disease 2019 (COVID‐19), caused by SARS‐CoV‐2, has been associated with thrombotic complications in adults and children. Cerebral sinovenous thrombosis (CSVT) has also been described in adults with SARS‐CoV‐2, though rarely reported in children.

Objective

To describe cases of SARS‐CoV‐2‐related pediatric CSVT among patients enrolled in the International Pediatric Stroke Study.

Methods

We enrolled pediatric patients (0–18 years) with a CSVT diagnosis between March 1, 2020 and March 1, 2023, positive for SARS‐CoV‐2.

Results

Nineteen cases (median age: 9 years; IQR: 3–16) from 4 countries and 12 institutions met eligibility criteria. We found thrombosis of the superficial venous system in 90%, arterial ischemic strokes in 11%, and venous infarcts in 26% of patients. All patients had an additional thrombosis risk factor, including 63% with a positive hypercoagulability evaluation and coinfection present in 58%. Eighteen patients (95%) received antithrombotics. Outcome data were reported in16/19 (84%) (median follow‐up of 12 months [IQR: 5‐28]) showing partial recanalization in nine, full recanalization in four, and no recanalization in three.

Conclusion

CSVT appears to be a rare thrombotic complication of pediatric SARS‐CoV‐2 infection. However, all patients in our case series had additional risk factors for thrombosis, making it difficult to determine the relationship between SARS‐CoV‐2 infection and CSVT development. The majority of patients had anticoagulation and among 16 patients with follow‐up data, 80% demonstrated CSVT resolution or improvement. Despite this, 38% had neurological deficits at follow‐up. These findings are consistent with those reported in previous pediatric CSVT case series.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Sinus Thrombosis, IntracranialSARS-CoV-2HumansChildFemaleChild, PreschoolAdolescentMaleInfantRisk FactorsPandemicsFollow-Up Studies

Stichwörter der Autor:innen

SARS‐CoV‐2anticoagulationintracranial venous thrombosispediatric

Autor:innen und Institutionen

  • Department of Hematology and Oncology, Cook Children's Hematology and Oncology Center, Fort Worth, Texas, USA.
  • Department of Clinical and Translational Sciences, Cook Children's Hematology and Oncology Center, Fort Worth, Texas, USA.
  • Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
  • Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Pediatrics, Division of Pediatric Neurology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

ORCID-Profile: Allyson Schenk, Riten Kumar, Jonathan D Santoro

Zitieren

APA

Torres, M., Schenk, A., Kumar, R., Lehman, L., Hassanein, S. M. A., Amlie-Lefond, C., Bernard, T. J., Cavanaugh, B. A., Lakhotia, A., Dlamini, N., Santoro, J. D., Taylor, J. M., Zuñiga, Y. C., Beslow, L. A., & International Pediatric Stroke Study (2026). Pediatric Cerebral Sinus Venous Thrombosis During the First Three Years of the SARS‐CoV‐2 Pandemic: A Multinational Case Series. Pediatric Blood & Cancer, 73(10). https://doi.org/10.1002/1545-5017.70566

Vancouver

Torres M, Schenk A, Kumar R, Lehman L, Hassanein SMA, Amlie-Lefond C, et al. Pediatric Cerebral Sinus Venous Thrombosis During the First Three Years of the SARS‐CoV‐2 Pandemic: A Multinational Case Series. Pediatric Blood & Cancer. 2026;73(10). doi:10.1002/1545-5017.70566

BibTeX
@article{Torres2026,
  author = {Torres, Marcela and Schenk, Allyson and Kumar, Riten and Lehman, Laura and Hassanein, Sahar M A and Amlie-Lefond, Catherine and Bernard, Timothy J and Cavanaugh, Beth Anne and Lakhotia, Arpita and Dlamini, Nomazulu and Santoro, Jonathan D and Taylor, J Michael and Zuñiga, Yenny C and Beslow, Lauren A and International Pediatric Stroke Study, International Pediatric Stroke Study},
  title = {Pediatric Cerebral Sinus Venous Thrombosis During the First Three Years of the SARS‐CoV‐2 Pandemic: A Multinational Case Series},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  volume = {73},
  number = {10},
  doi = {10.1002/1545-5017.70566}
}
Kostenlos starten →